ClinVar Miner

Submissions for variant NM_000368.5(TSC1):c.1163T>C (p.Leu388Pro)

gnomAD frequency: 0.00041  dbSNP: rs377598226
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000734481 SCV000514993 likely benign not provided 2021-02-23 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 26226092)
Labcorp Genetics (formerly Invitae), Labcorp RCV001083120 SCV000552299 benign Tuberous sclerosis 1 2024-01-30 criteria provided, single submitter clinical testing
Ambry Genetics RCV000567359 SCV000675368 likely benign Hereditary cancer-predisposing syndrome 2021-09-30 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Eurofins Ntd Llc (ga) RCV000734481 SCV000862627 uncertain significance not provided 2018-08-22 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001083120 SCV002040123 likely benign Tuberous sclerosis 1 2021-11-07 criteria provided, single submitter clinical testing
Sema4, Sema4 RCV000567359 SCV002530879 likely benign Hereditary cancer-predisposing syndrome 2021-02-17 criteria provided, single submitter curation
Revvity Omics, Revvity RCV000734481 SCV004236972 uncertain significance not provided 2023-05-22 criteria provided, single submitter clinical testing
All of Us Research Program, National Institutes of Health RCV003995989 SCV004840479 uncertain significance Tuberous sclerosis syndrome 2024-02-05 criteria provided, single submitter clinical testing This missense variant replaces leucine with proline at codon 388 of the TSC1 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with tuberous sclerosis complex in the literature. This variant has been identified in 20/281880 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
Myriad Genetics, Inc. RCV001083120 SCV005404692 likely benign Tuberous sclerosis 1 2024-08-09 criteria provided, single submitter clinical testing This variant is considered likely benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance.
PreventionGenetics, part of Exact Sciences RCV003902488 SCV004724564 likely benign TSC1-related disorder 2023-07-17 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.